CPT code 30117 denotes the surgical excision or destruction of a lesion of the nose performed via an internal (endonasal) approach. This code captures procedures in which instruments are introduced into the nasal cavity to remove or ablate intranasal lesions. Nationally, accurate coding for this procedure is important for clinical documentation, surgical quality metrics, and consistent payment across facility settings.

Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of typical sites of service and service type, common modifiers used with this code, and where available, comparative benchmarks and policy context relevant to payers nationally. The summary addresses coding considerations, expected clinical context for use, and common billing modifiers that may affect claim processing.

This publication offers a concise reference for billers, coders, and administrative leaders seeking clarity on the clinical definition of CPT code 30117, its typical settings, and what to expect in payer coverage and adjudication practices. Data not available in the input will be noted where relevant.